Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
To estimate the efficacy of Gemcitabine monotherapy compared to UFT as the post operative adjuvant chemotherapy for completely resected non-small cell lung cancer.
Epistemonikos ID: 455a156ee957dcc07fbb1470f0b04fe7119e2415
First added on: May 04, 2024